Skip to main navigation

About People Science Pipeline Patients Investors Careers

Overview
Vision & Values
Founder's Letter
Contact

Overview
Leadership Team
Board of Directors
Scientific Advisory Board
R&D Advisory Board

RAS/MAPK Pathway
MAPKlamp & More
Presentations & Publications

Pipeline
Programs
Clinical Trials

Patients & Caregivers
Clinical Trials

Corporate Overview
News & Events
Stock Information
Corporate Governance
Financial Information
Investor Resources

Dynamic Culture
Values & Attributes
Competitive Benefits
Open Positions

Stay in Touch

858.465.6511
info@erasca.com

News & Events

News Releases
Erasca in the News
Events
Presentations

News Releases

Year

04.27.2026

Erasca Announces Positive Preliminary Phase 1 Dose Escalation Data for Potentially Best-in-Class Pan-RAS Molecular Glue ERAS-0015 in KRAS-Mutant Solid Tumors

04.27.2026

Erasca to Host Conference Call and Webcast to Discuss Preliminary Phase 1 Dose Escalation Data for Potentially Best-in-Class Pan-RAS Molecular Glue ERAS-0015

03.12.2026

Erasca Reports Fourth Quarter and Full Year 2025 Business Updates and Financial Results

03.10.2026

Erasca Exercises Option to Secure Worldwide Rights for ERAS-0015 Pan-RAS Molecular Glue to Include China, Hong Kong, and Macau

03.05.2026

Erasca and Tango Therapeutics Enter into Clinical Collaboration to Evaluate Combination of ERAS-0015 and Vopimetostat

02.24.2026

Erasca Announces Issuance of a U.S. Patent Covering Pan-KRAS Inhibitor ERAS-4001

02.05.2026

Erasca to Present at Upcoming Conferences in February

01.23.2026

Erasca Announces Closing of Upsized Public Offering of Common Stock, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

01.21.2026

Erasca Announces Pricing of Upsized Public Offering of Common Stock

01.20.2026

Erasca Announces Proposed Public Offering of $150 Million of Common Stock

Pagination

Current page 1
Page 2
Next page
Last page

Displaying 1 - 10 of 12

Site - Investor Tools

Contact Us

info@erasca.com

Location

ERASCA, INC.

3115 Merryfield Row

Suite 300

San Diego, CA 92121

Terms of Use
Privacy Policy
Erasca Foundation
Erasca Ventures

© 2026 Erasca^®, Inc. All rights reserved.